Search

Author/Creator Ochi, Takashi

2. Gene Signature–Based Approach Identified MEK1/2 as a Potential Target Associated With Relapse After Anti-TNFα Treatment for Crohn's Disease. Issue 6 (13th April 2018)

Authors:
Gamo, Kanae; Okuzono, Yuumi; Yabuki, Masato; Ochi, Takashi; Sugimura, Kyoko; Sato, Yosuke; Sagara, Masaki; Hayashi, Hiroki; Ishimura, Yoshimasa; Nishimoto, Yutaka; Murakawa, Yusuke; Shiokawa, Zenyu; Gotoh, Masayuki; Miyazaki, Takahiro; Ebisuno, Yukihiko
Journal:
Inflammatory bowel diseases
Issue:
Volume 24:Issue 6(2018)
Page Start:
1251
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

3. Gene Signature–Based Approach Identified MEK1/2 as a Potential Target Associated With Relapse After Anti-TNFα Treatment for Crohn's Disease. Issue 6 (18th May 2018)

Authors:
Gamo, Kanae; Okuzono, Yuumi; Yabuki, Masato; Ochi, Takashi; Sugimura, Kyoko; Sato, Yosuke; Sagara, Masaki; Hayashi, Hiroki; Ishimura, Yoshimasa; Nishimoto, Yutaka; Murakawa, Yusuke; Shiokawa, Zenyu; Gotoh, Masayuki; Miyazaki, Takahiro; Ebisuno, Yukihiko
Journal:
Inflammatory bowel diseases
Issue:
Volume 24:Issue 6(2018)
Page Start:
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗